Multi-class cancer classification through gene expression profiles: microRNA versus mRNA
- PMID: 19631915
- DOI: 10.1016/S1673-8527(08)60130-7
Multi-class cancer classification through gene expression profiles: microRNA versus mRNA
Abstract
Both microRNA (miRNA) and mRNA expression profiles are important methods for cancer type classification. A comparative study of their classification performance will be helpful in choosing the means of classification. Here we evaluated the classification performance of miRNA and mRNA profiles using a new data mining approach based on a novel SVM (Support Vector Machines) based recursive feature elimination (nRFE) algorithm. Computational experiments showed that information encoded in miRNAs is not sufficient to classify cancers; gut-derived samples cluster more accurately when using mRNA expression profiles compared with using miRNA profiles; and poorly differentiated tumors (PDT) could be classified by mRNA expression profiles at the accuracy of 100% versus 93.8% when using miRNA profiles. Furthermore, we showed that mRNA expression profiles have higher capacity in normal tissue classifications than miRNA. We concluded that classification performance using mRNA profiles is superior to that of miRNA profiles in multiple-class cancer classifications.
Similar articles
-
MicroRNA involvement in the pathogenesis and management of breast cancer.J Clin Pathol. 2009 May;62(5):422-8. doi: 10.1136/jcp.2008.060681. J Clin Pathol. 2009. PMID: 19398594 Review.
-
MicroRNA expression profiling in cancer from a bioinformatics prospective.Expert Rev Mol Diagn. 2007 Nov;7(6):787-92. doi: 10.1586/14737159.7.6.787. Expert Rev Mol Diagn. 2007. PMID: 18020908 Review.
-
MicroRNA expression profile based cancer classification using Default ARTMAP.Neural Netw. 2009 Jul-Aug;22(5-6):774-80. doi: 10.1016/j.neunet.2009.06.018. Epub 2009 Jul 1. Neural Netw. 2009. PMID: 19632086
-
Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.Genes Chromosomes Cancer. 2009 Dec;48(12):1069-82. doi: 10.1002/gcc.20709. Genes Chromosomes Cancer. 2009. PMID: 19760605
-
MicroRNAs and cancer.APMIS. 2007 Oct;115(10):1090-106. doi: 10.1111/j.1600-0463.2007.apm_775.xml.x. APMIS. 2007. PMID: 18042145 Review.
Cited by
-
A Stack-based Ensemble Framework for Detecting Cancer MicroRNA Biomarkers.Genomics Proteomics Bioinformatics. 2017 Dec;15(6):381-388. doi: 10.1016/j.gpb.2016.10.006. Epub 2017 Dec 12. Genomics Proteomics Bioinformatics. 2017. PMID: 29246520 Free PMC article.
-
Quantification of read species behavior within whole genome sequencing of cancer genomes for the stratification and visualization of genomic variation.Nucleic Acids Res. 2016 May 19;44(9):e81. doi: 10.1093/nar/gkw031. Epub 2016 Jan 24. Nucleic Acids Res. 2016. PMID: 26809676 Free PMC article.
-
Identification of miRNA Biomarkers for Diverse Cancer Types Using Statistical Learning Methods at the Whole-Genome Scale.Front Genet. 2020 Nov 13;11:982. doi: 10.3389/fgene.2020.00982. eCollection 2020. Front Genet. 2020. PMID: 33281862 Free PMC article.
-
microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2.Oncol Lett. 2013 Dec;6(6):1713-1718. doi: 10.3892/ol.2013.1609. Epub 2013 Oct 9. Oncol Lett. 2013. PMID: 24260067 Free PMC article.
-
Circulating miR-17 as a promising diagnostic biomarker for lung adenocarcinoma: evidence from the Gene Expression Omnibus.Transl Cancer Res. 2020 Sep;9(9):5544-5554. doi: 10.21037/tcr-19-3025. Transl Cancer Res. 2020. PMID: 35117918 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources